UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
(Address of principal executive offices) |
(Zip Code)
|
Registrant’s telephone number, including
area code: (
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Toronto Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 1.01. Entry into a Material Definitive Agreement.
On April 13, 2023, Gatos Silver, Inc. (the “Company”) entered into a waiver (the “Waiver”) to its Amended and Restated Revolving Credit Agreement, dated December 20, 2022, among the Company, certain of its subsidiaries from time to time, Bank of Montreal, Chicago Branch, as administrative agent, BMO Capital Markets, as bookrunner and mandated lead arranger, and Bank of Montreal, Chicago Branch and certain financial institutions from time to time, as lenders. The Waiver deferred the Company’s obligation to deliver until May 15, 2023 (i) its audited consolidated financial statements and the Los Gatos Joint Venture’s (the “LGJV”) audited combined financial statements for the years ended December 31, 2021 and 2022, together with the auditors’ report on such audited financial statements, and (ii) its unaudited consolidated financial statements and the LGJV’s unaudited combined financial statements for the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022.
The foregoing description of the Waiver is not complete and is qualified in its entirety by reference to the full text of the agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On April 18, 2023, the Company received a notice from the New York Stock Exchange (“NYSE”) stating that the Company was not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission.
As disclosed in the Company’s Current Report on Form 8-K filed on April 3, 2023, on March 31, 2023, the Company determined that there was an understatement in the net deferred tax assets in its 70%-owned LGJV that originated in 2021. The Company is in the process of restating the previously issued financial statements of the Company and of the LGJV for the year ended December 31, 2021 and the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022 (the “Affected Periods”). The Company is assessing the impact of the timing and recognition of the priority distribution obligation and subsequent payments on the previously recognized income from affiliates. The Company is also unable to file its Annual Report on Form 10-K for the year ended December 31, 2022 until the restatement of the financial statements for the Affected Periods is complete.
In accordance with Section 802.01E of the NYSE Listed Company Manual, the NYSE will closely monitor the status of the Company’s late filing and related public disclosures for up to six months from the date of the filing delinquency (the “Initial Cure Period”). The Company’s common stock will continue to trade on the NYSE during the Initial Cure Period, subject to the Company’s compliance with other continued listing requirements. Notwithstanding the foregoing, if circumstances warrant, the NYSE may commence delisting proceedings at any time.
The Company is working expeditiously to complete and file its Annual Report on Form 10-K for the year ended December 31, 2022, along with restatements of previously issued financial statements of the Company and of the LGJV for the year ended December 31, 2021 and the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022.
The Company issued a press release announcing the receipt of the notice from the NYSE. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.
Item 8.01. Other Events.
The Company announced that it has postponed its Annual Meeting of Stockholders previously scheduled for May 31, 2023. The meeting will be rescheduled once all required filings with the U.S. Securities and Exchange Commission are filed.
In connection with the foregoing matters, the Company issued a press release. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. |
Description | |
10.1 | Wavier No. 4 to the Amended and Restated Revolving Credit Agreement, dated December 20, 2022, among Gatos Silver, Inc., certain subsidiaries of Gatos Silver, Inc. from time to time, Bank of Montreal, Chicago Branch, as administrative agent, BMO Capital Markets, as bookrunner and mandated lead arranger, and Bank of Montreal, Chicago Branch and certain financial institutions from time to time, as lenders | |
99.1 | Press Release, dated April 18, 2023 | |
99.2 | Press Release, dated April 17, 2023 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GATOS SILVER, INC. | ||||||
Date: April 19, 2023 | By: |
/s/ Dale Andres | ||||
Dales Andres | ||||||
Chief Executive Officer |
Exhibit 10.1
THIS WAIVER NO. 4 TO THE REVOLVING CREDIT FACILITY (this "Waiver") is dated April 13, 2023 (the "Effective Date") and made between:
(1) | GATOS SILVER, INC., a corporation existing under the Laws of Delaware, and its successors and permitted assigns (the “Borrower”); |
(2) | CERTAIN SUBSIDIARIES OF THE BORROWER from time to time, (collectively, the “Guarantors”); |
(3) | BANK OF MONTREAL, CHICAGO BRANCH and CERTAIN FINANCIAL INSTITUTIONS from time to time, as lenders (the “Lenders”); |
(4) | BANK OF MONTREAL, CHICAGO BRANCH as bookrunner and mandated lead arranger (the “Arranger”); and |
(5) | BANK OF MONTREAL, CHICAGO BRANCH, in its capacity as administrative agent for and on behalf of the Lenders (the "Administrative Agent"). |
RECITALS:
(A) | Certain credit facilities were made available to the Borrower pursuant to the amended and restated revolving credit facility dated as of December 20, 2022 (the “Facility Agreement”) among, inter alia, the Borrower, as borrower, the Guarantors, as guarantors (the Borrower and the Guarantors, collectively, the “Obligors”), the Administrative Agent, as administrative agent, the Arranger, as Bookrunner and mandated lead arranger, and the Lenders, as lenders. |
(B) | Pursuant to Section 11.1(b)(vi) the Borrower was to provide no later than April 15, 2023, audited consolidated financial statements of the Borrower and audited combined financial statements of the LGJV, together with the auditors’ report on such audited financial statements in form satisfactory to the Majority Lenders, acting reasonably, for the 2021 Fiscal Year. |
(C) | Pursuant to Section 11.1(b)(vii) the Borrower was to provide no later than April 30, 2023, audited consolidated financial statements of the Borrower and audited combined financial statements of the LGJV, together with the auditors' report on such audited financial statements in form satisfactory to the Majority Lenders, acting reasonably, for the 2022 Fiscal Year; and unaudited consolidated financial statements of the Borrower and unaudited combined financial statements of the LGJV in form satisfactory to the Majority Lenders, acting reasonably, for the first three Fiscal Quarters of the 2022 Fiscal Year; |
(D) | The Borrower has requested a further waiver of its obligations under Sections 11.1(b)(vi) and 11.1(b)(vii) from April 15, 2023 and April 30, 2023, respectively, to May 15, 2023. |
(E) | The Administrative Agent and each of the Lenders are willing to agree, subject to the terms and conditions set forth in this Waiver, to provide certain waivers to the Facility Agreement as set forth in this Agreement. |
NOW THEREFORE, in consideration of the foregoing premises and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, the parties agree as follows:
- 2 -
1 | Interpretation |
1.1 | Capitalized terms used in this Waiver and not otherwise defined have the meanings given to them in the Facility Agreement. |
1.2 | This Waiver constitutes a Credit Document under the Facility Agreement and the other Finance Documents. |
1.3 | The recitals and statements set out above are true and correct and are hereby incorporated into this Waiver. |
2 | Waiver |
In reliance by the Lenders and the Administrative Agent on the representations and warranties made by the Borrower in Section 3, and notwithstanding anything to the contrary in the Facility Agreement or any Finance Document, the Administrative Agent and the Lenders hereby waive the Borrower’s obligations to deliver financial statements under Sections 11.1(b)(vi) and 11.1(b)(vii); provided, however, that the Borrower shall furnish the financial statements required to be furnished under Sections 11.1(b)(vi) and 11.1(b)(vii) as soon as practicable and, in any event, no later than May 15, 2023.
3 | Representations and Warranties |
3.1 | Each Obligor represents and warrants to the Administrative Agent and the Lenders as follows: |
(a) | the recitals to this Waiver are true and complete; |
(b) | the representations and warranties of the Obligors contained in the Finance Documents are true and complete and are not misleading as of the Effective Date, other than to the extent such representations and warranties of the Obligors are not true and complete as a result solely of the Mineral Reserve Estimate Defaults, including, without limitation, any action, suit, inquiry, claim or other proceeding arising out of the Mineral Reserve Estimate Defaults for which no judgment or award has been granted against any Obligor, and which is being diligently contested in good faith by appropriate proceedings by the Borrower; |
(c) | each Obligor is in full compliance with all of its covenants in the Finance Documents, other than as waived by the Facility Agreement and herein; and |
(d) | no Default or Event of Default, other than as waived by the Facility Agreement and herein, has occurred or is continuing or would result from the execution and delivery of this Waiver. |
4 | Continuing Obligations |
4.1 | The matters granted in this Waiver are strictly limited to the matters and upon the conditions set out herein and shall not be construed as the granting of or a right to any waiver of any other provision. |
- 3 -
4.2 | Except as expressly provided in Section 2 above, nothing in this Waiver shall constitute an amendment, waiver, consent or release of any provision of, or any right or remedy of any party to the Facility Agreement, nor otherwise prejudice any right or remedy of any Finance Party under the Facility Agreement or any Finance Document. |
4.3 | Save to the extent varied or amended by this Waiver, the Facility Agreement remains in full force and effect in accordance with its terms and shall be read and construed with this Waiver as one instrument. |
5 | References to and Effect on Other Finance Documents |
5.1 | On and after the effectiveness of this Waiver, each reference in the Facility Agreement to "this Agreement", "the Revolving Credit Facility", "hereunder", "hereof" or words of like import referring to the Facility Agreement, and each reference in the other Finance Documents to "Facility Agreement", “Credit Agreement”, "thereunder", "thereof" or words of like import referring to the Facility Agreement, shall mean and be a reference to the Facility Agreement, as modified by this Waiver. |
5.2 | The Facility Agreement, as specifically modified by this Waiver, is and shall continue to be in full force and effect and is hereby in all respects ratified and confirmed. Without limiting the generality of the foregoing, the Security Documents shall continue to secure the payment of all obligations of the Obligors and Gatos Canada under the Finance Documents, as modified by this Waiver. |
5.3 | The execution, delivery and effectiveness of this Waiver shall not, except as expressly provided herein: (i) operate as a waiver of any right, power or remedy of any of the Finance Parties under any of the Finance Documents, nor constitute a waiver of any provision of any of the Finance Documents, (ii) prejudice any other right, power or remedy which the Finance Parties now have or may have in the future under or in connection with the Facility Agreement or the other Finance Documents, (iii) operate as a forbearance with respect to any of its rights or remedies concerning any Events of Default which may have occurred or are continuing as of the date hereof or which may occur after the date hereof, or (iv) be a novation of the obligations of the Obligors or Gatos Canada under any of the Finance Documents. |
6 | Incorporation by Reference |
Sections 1.5 (Currency), 1.6 (Applicable Law), 1.7 (Time of the Essence), 16.15 (Waivers and Amendments), 18.2 (Severability), 18.3 (Counterparts), 18.8 (Waiver of Jury Trial), and 18.10 (No Third-Party Beneficiaries) of the Facility Agreement are hereby incorporated by reference herein, mutatis mutandis.
[The remainder of this page intentionally left blank.]
IN WITNESS WHEREOF, the parties to this Waiver have executed and delivered this Waiver on the date first written above.
GATOS SILVER, Inc., as Borrower | ||
Per: | /s/ Andre Van Niekerk | |
Name: Andre Van Niekerk | ||
Title: CFO | ||
Per: | /s/ Nicolas Vachon | |
Name: Nicolas Vachon | ||
Title: VP Finance |
(Signature page to Waiver No. 3 to the Revolving Credit Facility)
BANK OF MONTREAL, CHICAGO BRANCH, as Lender | ||
Per: | /s/ Nada Elreedy | |
Name: Nada Elreedy | ||
Title: Director | ||
BANK OF MONTREAL, CHICAGO BRANCH, as Administrative Agent | ||
Per: | /s/ Nada Elreedy | |
Name: Nada Elreedy | ||
Title: Director |
(Signature page to Waiver No. 3 to the Revolving Credit Facility)
Exhibit 99.1
![]() |
925 W Georgia St, Suite 910 Vancouver, British Columbia V6C 3L2 (604) 424-0984 www.gatossilver.com |
GATOS SILVER RECEIVES NYSE NOTICE REGARDING 2022 10-K FILING
Vancouver, BC — April 18, 2023 — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) announced that, further to its announcement on April 17, 2023 that the Company intends to delay the filing of its Annual Report on Form 10-K (“2022 Form 10-K”), it received today a notice from the New York Stock Exchange (“NYSE”) stating that the Company was not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its 2022 Form 10-K with the U.S. Securities and Exchange Commission.
In accordance with Section 802.01E of the NYSE Listed Company Manual, the NYSE will closely monitor the status of the Company’s late filing and related public disclosures for up to six months from the date of the filing delinquency (the “Initial Cure Period”). The Company’s common stock will continue to trade on the NYSE during the Initial Cure Period, subject to the Company’s compliance with other continued listing requirements. Notwithstanding the foregoing, if circumstances warrant, the NYSE may commence delisting proceedings at any time. The Company has also requested an extension of the time to file the 2022 Form 10-K under the policies of the Toronto Stock Exchange.
As previously announced, the Company is working expeditiously to complete and file its 2022 Form 10-K along with restatements of previously issued financial statements of the Company and of the 70%-owned Los Gatos Joint Venture for the year ended December 31, 2021 and the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022.
About Gatos Silver
Gatos Silver is a silver dominant exploration, development and production company that discovered a new silver and zinc-rich mineral district in southern Chihuahua State, Mexico. As a 70% owner of the Los Gatos Joint Venture, the Company is primarily focused on operating the Cerro Los Gatos mine and on growth and development of the Los Gatos district. The LGJV consists of approximately 103,000 hectares of mineral rights, representing a highly prospective and under-explored district with numerous silver-zinc-lead epithermal mineralized zones identified as priority targets.
Forward-Looking Statements
This press release contains statements that constitute “forward looking information” and “forward-looking statements” within the meaning of U.S. and Canadian securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding timing of filing the Company’s Annual Report on Form 10-K, restatements of previously issued financial statements of the Company and of the 70%-owned Los Gatos Joint Venture, and the ability of the Company’s securities to continue to trade on the NYSE or the TSX. are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements, and such other risks and uncertainties described in our filings with the U.S. Securities and Exchange Commission and Canadian securities commissions. Gatos Silver expressly disclaims any obligation or undertaking to update the forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions, or circumstances on which such statements are based unless required to do so by applicable law. No assurance can be given that such future results will be achieved. Forward-looking statements speak only as of the date of this press release.
Investors and Media Contact
André van Niekerk
Chief Financial Officer
investors@gatossilver.com
(604) 424-0984
Page 1 of 1
Exhibit 99.2
![]() |
925 W Georgia St, Suite 910 Vancouver, British Columbia V6C 3L2 (604) 424-0984 www.gatossilver.com
|
GATOS SILVER PROVIDES UPDATE ON TIMING FOR FILING FINANCIAL STATEMENTS
Vancouver, BC — April 17, 2023 — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) today announced that it intends to delay the filing of its Annual Report on Form 10-K (“2022 Form 10-K’) for the fiscal year ended December 31, 2022 as well as its restatements of previously issued financial statements of the Company and of the 70%-owned Los Gatos Joint Venture (the “LGJV”) for the year ended December 31, 2021 and the quarters ended March 31, 2022, June 30, 2022 and September 30, 2022 (collectively, the “Securities Filings”).
The Company previously announced that it would endeavor to make the Securities Filings by April 17, 2023, but had also noted that the date was subject to change. The delay relates to the previously disclosed and ongoing analysis by the Company of required adjustments to its and the LGJV’s financial statements primarily regarding the timing and recognition of net deferred tax assets and liabilities at the LGJV. The Company is also assessing the impact of the timing and recognition of the priority distribution obligation and subsequent payments on the previously recognized income from affiliates. The analysis and work to finalize the required adjustments will require more time than previously anticipated. The Company continues to believe that these adjustments are non-cash items and will not affect the Company’s strong cash position.
The restatements and the 2022 full year financial results are subject to completion of a review and audit by the Company’s independent registered public accounting firm, Ernst & Young LLP (“EY”). The Company is working expeditiously to complete the required adjustments and expects to make the Securities Filings once the analysis described above and the review and audit work by EY is complete.
Gatos Silver has also postponed its Annual Meeting of Stockholders previously scheduled to be held on May 31, 2023. The meeting will be rescheduled once the Securities Filings are complete.
The Company has filed an updated Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission and is seeking additional time for complying with the continued listing standards of the New York Stock Exchange and the Toronto Stock Exchange regarding the filing of its 2022 Form 10-K.
The Company has received an extension to May 15, 2023 to fulfill the requirement to furnish outstanding financial statements under its revolving credit agreement.
About Gatos Silver
Gatos Silver is a silver dominant exploration, development and production company that discovered a new silver and zinc-rich mineral district in southern Chihuahua State, Mexico. As a 70% owner of the Los Gatos Joint Venture, the Company is primarily focused on operating the Cerro Los Gatos mine and on growth and development of the Los Gatos district. The LGJV consists of approximately 103,000 hectares of mineral rights, representing a highly prospective and under-explored district with numerous silver-zinc-lead epithermal mineralized zones identified as priority targets.
Forward-Looking Statements
This press release contains statements that constitute “forward looking information” and “forward-looking statements” within the meaning of U.S. and Canadian securities laws. All statements other than statements of historical facts contained in this press release, including statements regarding timing of filing the Company’s Securities Filings are based on management’s beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements, and such other risks and uncertainties described in our filings with the U.S. Securities and Exchange Commission and Canadian securities commissions. Gatos Silver expressly disclaims any obligation or undertaking to update the forward-looking statements contained in this press release to reflect any change in its expectations or any change in events, conditions, or circumstances on which such statements are based unless required to do so by applicable law. No assurance can be given that such future results will be achieved. Forward-looking statements speak only as of the date of this press release.
Investors and Media Contact
André van Niekerk
Chief Financial Officer
investors@gatossilver.com
(604) 424-0984
Page 1 of 1
Cover |
Apr. 13, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Apr. 13, 2023 |
Entity File Number | 001-39649 |
Entity Registrant Name | GATOS SILVER, INC. |
Entity Central Index Key | 0001517006 |
Entity Tax Identification Number | 27-2654848 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 925 W Georgia Street, Suite 910 |
Entity Address, City or Town | Vancouver |
Entity Address, State or Province | BC |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | V6C 2G3 |
City Area Code | 604 |
Local Phone Number | 424-0984 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | GATO |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | true |
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end
L.##+\P L+6
MN)K&IMI,%^FE9XKWW^6K&L3L[,8YA3?-FM?-E9PH#/.\$#!0@U08 BR74-7N,?:B%F^<
M3$20UH\H2E$O=5/'AKU(- 'A7U&$= >!D6._J*:O+]H?%?7YEZS/'Q?U^9Q6
M(U^QH/G=$#-J9!+?$6]Y8!G"A.Y*ROM(%8HP;:IRW$OV1=F#N)K(,(+ MT0H
MFUTNS76O%8[0V,45@!,]$=J!R + A4J8%U=V@P9/A;F(QG+77]S?G(54NHFJ
M->P.0),TA )$]RP:QKS7M/C:TN<]6?NW':6\